An Exploration of the History and Controversies Surrounding MDMA and MDA

REFERENCES

• Beck , J. 1990 . “ The public health implications of MDMA use. ” . In Ecstasy: The Clinical, Pharmacological, and Neurotoxicological Effects of the Drug MDMA. Edited by: Peroutka , S. J. Boston, Massachusetts : Kluwer Academic. .
   Google Scholar
• Beck , J. and Rosenbaum , M. 1994 . The Pursuit of Ecstasy: The MDMA Experience. New York : SUNY. .
   Google Scholar
• Byard , R. W. , Gilbert , J. , James , R. and Lokan , R. J. 1998 . Amphetamine derivative deaths in South Australia—Is “ecstasy” the culprit? . American Journal of Forensics and Medical Pathology , 19 : 261 – 65 .
   PubMed Web of Science ®Google Scholar
• Climko , R. P. , Roehrich , H. , Sweeny , D. R. and Al-razi , J. 1987 . Ecstasy: A review of MDMA and MDA . International Journal of Psychiatry in Medicine , 16 : 359 – 71 .
   Web of Science ®Google Scholar
• Dar , K. J. and McBrien , M. E. 1996 . MDMA induced hyperthermia: Report of a fatality and review of current therapy . Intensive Care Medicine , 22 : 995 – 6 .
   PubMed Web of Science ®Google Scholar
• De Boer , D. , Gijzels , M. J. , Bosman , I. J. and Maes , R. A.A. 1999 . More data about the new psychoactive drug 2C-B . Journal of Analytical Toxicology , 23 : 227 – 8 .
   PubMed Web of Science ®Google Scholar
• DeQuincy , T. 1995 . Confessions of an English Opium-Eater. New York : Dover Publications. . [1821]
   Google Scholar
• Dowling , G. P. 1990 . “ Human deaths and toxic reactions attributed to MDMA and MDEA. ” . In Ecstasy: the Clinical, Pharmacological, and Neurotoxicological Effects of the Drug MDMA. Edited by: Peroutka , S. J. Boston, Massachusetts : Kluwer Academic. .
   Google Scholar
• Frank , R. S. 1983 . The clandestine drug laboratory situation in the United States . Journal of Forensic Science , 28 : 18 – 31 .
   PubMed Web of Science ®Google Scholar
• Greer , G. R. and Tolbert , R. 1998 . A method of conducting therapeutic sessions with MDMA . Journal of Psychoactive Drugs , 30 : 371 – 79 .
   PubMed Web of Science ®Google Scholar
• Greer , G. R. and Tolbert , R. 1990 . “ The therapeutic use of MDMA. ” . In Ecstasy: The Clinical, Pharmacological, and Neurotoxicological Effects of the Drug MDMA. Edited by: Peroutka , S. J. Boston, Massachusetts : Kluwer Academic. .
   Google Scholar
• Grinspoon , L. and Bakalar , J. B. 1986 . Can drugs be used to enhance the psychotherapeutic process? . American Journal of Psychotherapy , 40 : 393 – 404 .
   PubMed Web of Science ®Google Scholar
• Grob , C. S. , Bravo , G. L. , Walsh , R. N. and Leister , M. B. 1992 . The MDMA-neurotoxicity controversy: Implications for clinical research with novel psychoactive drugs . Journal of Nervous and Mental Disease , 180 : 355 – 6 .
   PubMed Web of Science ®Google Scholar
• Gunn , J. A. , Gurd , M. R. and Sachs , I. 1939 . The action of some amines related to adrenaline: Methoxyphenylisopropylamines . Journal of Physiology , 95 : 485 – 500 .
   PubMedGoogle Scholar
• Hall , A. P. 1997 . Hyponatraemia, water intoxication and “ecstasy” . Intensive Care Medicine , 23 : 1289
   PubMed Web of Science ®Google Scholar
• Hardman , H. F. , Haavik , C. O. and Seevers , M. H. 1973 . Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals . Toxicology and Applied Pharmacology , 25 : 299 – 309 .
   PubMed Web of Science ®Google Scholar
• Harrington , R. D. , Woodward , J. A. , Hooton , T. M. and Horn , J. R. 1999 . Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate . Archives of Internal Medicine , 159 : 2221 – 4 .
   PubMed Web of Science ®Google Scholar
• Henry , J. A. 2000 . Personal communication
   Google Scholar
• Hegadoren , K. M. 1995 . Metabolic, Behavioral, and Neurochemical Studies of 3,4-Methylenedioxy Analogues of Amphetamine. , PhD. Thesis Edmonton, Alberta, , Canada : University of Alberta. .
   Google Scholar
• Hegadoren , K. M. , Baker , G. B. and Bourin , M. 1999 . 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans . Neuroscience and Biobehavioral Review , 23 : 539 – 55 .
   PubMed Web of Science ®Google Scholar
• Holden , R. and Jackson , M. A. 1996 . Near fatal hyponatraemic coma due to vasopressin over-secretion after “ecstasy” (3,4-MDMA) . Lancet , 347 : 1052
   PubMed Web of Science ®Google Scholar
• Klassen , C. D. and Watkins , J. B. 1999 . Cassarett and Doull's Toxicology: The Basic Science of Poisons, Fifth Ed. Companion Handbook. New York : McGraw-Hill. .
   Google Scholar
• Loman , J. , Myerson , P. G. and Myerson , A. 1941 . Experimental pharmacology of post-encephalitic Parkinson's disease . Trans-American Neurology Association , 67 : 201 – 03 .
   Google Scholar
• Matthai , S. M. , Davidson , D. C. , Sills , J. A. and Alexandrou , D. 1996 . Cerebral oedema after ingestion of MDMA (“Ecstasy”) and unrestricted intake of water . British Medical Journal , 312 : 1359
   PubMed Web of Science ®Google Scholar
• Milosevic , A. , Agrawal , N. , Redfearn , P. J. and Mair , L. H. 1999 . The occurrence of toothwear in users of ecstasy (3,4- methylenedioxymethamphetamine) . Community Dentistry and Oral Epidemiology , 27 : 283 – 7 .
   PubMed Web of Science ®Google Scholar
• Milroy , C. M. 1999 . Ten years of “ecstasy.” . Journal of the Royal Society of Medicine , 92 : 68 – 72 .
   PubMed Web of Science ®Google Scholar
• Molliver , D. C. and Molliver , M. E. 1990 . Anatomic evidence for a neurotoxic effect of fenfluramine upon serotonergic projections in the rat . Brain Research , 511 : 165 – 68 .
   PubMed Web of Science ®Google Scholar
• Naranjo , C. , Shulgin , A. T. and Sargent , T. 1967 . Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy . Medicina et Pharmacologia Experimentalis , 17 : 359 – 64 .
   PubMedGoogle Scholar
• Nichols , D. E. 2000 . Personal communication
   Google Scholar
• Nichols , D. E. 1986 . Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens . Journal of Psychoactive Drugs , 18 : 305 – 13 .
   PubMed Web of Science ®Google Scholar
• Nichols , D. E. , Hoffman , A. J. , Oberlender , R. A. , Jacob , P. and Shulgin , A. T. 1986 . Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: Representatives of a novel therapeutic class . Journal of Medicinal Chemistry , 29 : 2009 – 15 .
   PubMed Web of Science ®Google Scholar
• Parr , M. J.A. , Low , H. M. and Botterill , P. 1997 . Hyponatremia and death after “ecstasy” ingestion . Medical Journal of Australia , 166 : 136 – 7 .
   PubMed Web of Science ®Google Scholar
• Pellerin , C. 1998 . Trips: How Hallucinogens Work in Your Brain. New York : Seven Stories Press. .
   Google Scholar
• Peroutka , S. J. 1990a . “ Preface. ” . In Ecstasy: The Clinical, Pharmacological, and Neurotoxicological Effects of the Drug MDMA. Edited by: Peroutka , S. J. Boston, Massachusetts : Kluwer Academic. .
   Google Scholar
• Peroutka , S. J. 1990b . “ Recreational use of MDMA. ” . In Ecstasy: the Clinical, Pharmacological, and Neurotoxicological Effects of the Drug MDMA. Edited by: Peroutka , S. J. Boston, Massachusetts : Kluwer Academic. .
   Google Scholar
• Plotinus . 1991 . The Enneads. Edited by: MacKenna , Stephen and Dillon , John . New York : Penguin Books. .
   Google Scholar
• Price , L. H. , Ricaurte , G. A. , Krystal , J. H. and Henninger , G. R. 1989 . Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxyamphetamine (MDMA) users . Archives of General Psychiatry , 46 : 20 – 22 .
   PubMedGoogle Scholar
• Ramsey J. (London Toxicology Group) . 2000 . Personal communication
   Google Scholar
• Riedlinger , J. E. 1985 . The scheduling of MDMA: A pharmacist's perspective . Journal of Psychoactive Drugs , 17 : 167 – 71 .
   PubMed Web of Science ®Google Scholar
• Riedlinger , T. J. and Riedlinger , J. E. 1994 . Psychedelic and entactogenic drugs in the treatment of depression . Journal of Psychoactive Drugs , 26 : 41 – 55 .
   PubMed Web of Science ®Google Scholar
• Rochester , J. A. and Kirchner , J. T. 1998 . Ecstasy (3,4-methylenedioxymethampetamine): History, neurochemistry, and toxicology . Journal of the American Board of Family Practitioners , 12 : 137 – 42 .
   Google Scholar
• Sferios , E. 1999 . Laboratory analysis program reveals DXM tablets sold as “ecstasy.” . Bulletin of the Multidisciplinary Association for Psychedelic Studies , 9 ( 4 ) : 47 – 8 .
   Google Scholar
• Shewan , D. , Dalgarno , P. and King , L. A. 1996 . . Such as ketamine . British Medical Journal , 313 : 424
   PubMed Web of Science ®Google Scholar
• Shulgin , A. T. 2000 . Personal communication
   Google Scholar
• Shulgin , A. T. 1990 . “ History of MDMA. ” . In Ecstasy: The Clinical, Pharmacological, and Neurotoxicological Effects of the Drug MDMA. Edited by: Peroutka , S. J. Boston, Massachusetts : Kluwer Academic. .
   Google Scholar
• Shulgin , A. T. 1986 . The background and chemistry of MDMA . Journal of Psychoactive Drugs , 18 : 291 – 304 .
   PubMed Web of Science ®Google Scholar
• Shulgin , A. T. 1978 . “ Psychomimetic drugs: Structure-activity relationships. ” . In Handbook of Psychopharmacology. Edited by: Iverson , L. L. , Iverson , S. D. and Snyder , S. H. New York : Plenum Press. .
   Google Scholar
• Shulgin , A. T. and Nichols , D. E. 1978 . “ Characterization of three new psychomimetics. ” . In The Psychopharmacology of Hallucinogens. Edited by: Stillman and Willette . New York : Pergamon Press. .
   Google Scholar
• Shulgin , A. and Shulgin , A. 1997 . TIHKAL: The Continuation. Berkeley, California : Transform Press. .
   Google Scholar
• Shulgin , A. and Shulgin , A. 1990 . PIHKAL: A Chemical Love Story. Berkeley, CA : Transform Press. .
   Google Scholar
• Sprague , J. E. , Everman , S. L. and Nichols , D. E. 1998 . An integrated hypothesis for the serotonergic axonal loss induced by 3,4- methylenedioxymethamphetamine . Neurotoxicology , 19 : 427 – 42 .
   PubMed Web of Science ®Google Scholar
• Vollenweider , F. X. , Remensberger , S. , Hell , D. and Geyer , M. A. 1999 . Opposite effects of 3,4-methylenedioxyamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans . Psychopharmacology , 143 : 365 – 372 .
   PubMed Web of Science ®Google Scholar
• White , J. M. , Bochner , F. and Irvine , R. J. 1997 . The agony of “ecstasy.” . Medical Journal of Australia , 166 : 117 – 18 .
   PubMed Web of Science ®Google Scholar
• Winstock , A. R. and King , L. A. 1996 . Tablets often contain substances in addition to, or instead of, ecstasy. . British Medical Journal , 313 : 423 – 4 .
   PubMedGoogle Scholar
• Wu , D. , Otton , S. V. , Inaba , T. , Kalow , W. and Sellers , E. M. 1997 . Interactions of amphetamine analogs with human liver CYP2D6 . Biochemical Pharmacology , 53 : 1605 – 12 .
   PubMed Web of Science ®Google Scholar